UnitedHealthcare Donates $1 Million to Nonprofits in Michigan

Funding is part of UnitedHealthcare’s $11 million in Empowering Health grants focused on expanding access to care and addressing the social determinants of health for people in underserved communities DETROIT–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $1 million in Empowering Health grants to five community-based organizations in Michigan to expand access to … [Read more…]

UnitedHealthcare Donates $500,000 to Nonprofits in Oklahoma

Funding is part of UnitedHealthcare’s $11 million in Empowering Health grants focused on expanding access to care and addressing the social determinants of health for people in underserved communities OKLAHOMA CITY–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is awarding $500,000 in Empowering Health grants to three community-based organizations in Oklahoma to expand access to … [Read more…]

Tivic Health to Report Second Quarter 2022 Earnings on August 15 Via Conference Call and Webcast

SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the second quarter of 2022 via conference call and webcast, Monday, August 15, 2022, at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll-Free: 877-545-0320 … [Read more…]

Aro Biotherapeutics Receives FDA Orphan Drug Designation for ABX1100 for the Treatment of Pompe Disease

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in the muscle, for the treatment of Pompe disease. “We are pleased to have received this designation … [Read more…]

Manatt Expands Data Strategy and Health IT Capabilities in Boston

BOSTON–(BUSINESS WIRE)–Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Cynthia Bero has joined its Boston office as a Manatt Health senior advisor. Bero joins Manatt from Mass General Brigham (MGB), where she spent over 20 years in senior information technology positions, most recently as Vice President of Information Systems. … [Read more…]

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Former Generate Biomedicines, Amgen and Novartis senior leader Mike Nohaile joins Prellis as CEO SAN FRANCISCO–(BUSINESS WIRE)–Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from … [Read more…]

Operation Lifesaver Launches New Animated Rail-Safety Campaign for Young Canadians

OTTAWA, Onatrio–(BUSINESS WIRE)–#RailSafety—Operation Lifesaver (OL) Canada, a national not-for-profit dedicated to rail safety, today launched a new public-awareness campaign aimed at educating young Canadians about the importance of obeying all rail safety signs and signals. Designed to appeal to youth between 13 and 24, the Seriously. Read the Signs. campaign takes a light-hearted approach to … [Read more…]

Versant Ventures Launches Vector BioPharma AG

— Transformational precision gene delivery company launched out of Versant’s Ridgeline Discovery Engine – — Vector developing platform for precisely targeted delivery of high-capacity genetic payloads — BASEL, Switzerland–(BUSINESS WIRE)–Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid of viral genes. Versant … [Read more…]

Ocular Therapeutix™ to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on Wednesday, August 17, 2022: Pre-Recorded Corporate Presentation Date: Wednesday, August 17, 2022 … [Read more…]

Get Well’s Remote Monitoring Program Reported To Improve COVID-19 Outcomes In Froedtert Study

Patient engagement leader expands commitment to driving digital health technology as pandemic continues BETHESDA, Md,–(BUSINESS WIRE)–#Adventist–Patients using a remote patient monitoring program developed by Get Well, a global leader in digital patient engagement, to monitor and report COVID-19 symptoms had lowered hospitalization rates, spent less time in the intensive care unit, and had shorter overall … [Read more…]